Report Detail
Global Diabetes Drug Therapy Market Professional Survey Report 2019
- RnM3792879 |
- 30 September, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Pharma & Healthcare
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
The global Diabetes Drug Therapy market was valued at 10000 million US$ in 2018 and will reach 21400 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2019-2025.
This report focuses on Diabetes Drug Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diabetes Drug Therapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Diabetes Drug Therapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Diabetes Drug Therapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Glucagon-like peptide-1 (GLP-1) agonist
Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Sodium glucose co-transporter 2 (SGLT2) inhibitors
Insulin
Others
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
Table of Contents
Executive Summary
1 Industry Overview of Diabetes Drug Therapy
- 1.1 Definition of Diabetes Drug Therapy
- 1.2 Diabetes Drug Therapy Segment by Type
- 1.2.1 Global Diabetes Drug Therapy Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Glucagon-like peptide-1 (GLP-1) agonist
- 1.2.3 Dipeptidyl-peptidase-4 (DPP-4) inhibitors
- 1.2.4 Sodium glucose co-transporter 2 (SGLT2) inhibitors
- 1.2.5 Insulin
- 1.2.6 Others
- 1.3 Diabetes Drug Therapy Segment by Applications
- 1.3.1 Global Diabetes Drug Therapy Consumption Comparison by Applications (2014-2025)
- 1.3.2 Type 1 Diabetes
- 1.3.3 Type 2 Diabetes
- 1.3.4 Gestational Diabetes
- 1.3.5 Impaired Glucose Tolerance and Impaired Fasting Glycaemia
- 1.4 Global Diabetes Drug Therapy Overall Market
- 1.4.1 Global Diabetes Drug Therapy Revenue (2014-2025)
- 1.4.2 Global Diabetes Drug Therapy Production (2014-2025)
- 1.4.3 North America Diabetes Drug Therapy Status and Prospect (2014-2025)
- 1.4.4 Europe Diabetes Drug Therapy Status and Prospect (2014-2025)
- 1.4.5 China Diabetes Drug Therapy Status and Prospect (2014-2025)
- 1.4.6 Japan Diabetes Drug Therapy Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Diabetes Drug Therapy Status and Prospect (2014-2025)
- 1.4.8 India Diabetes Drug Therapy Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Diabetes Drug Therapy
- 2.3 Manufacturing Process Analysis of Diabetes Drug Therapy
- 2.4 Industry Chain Structure of Diabetes Drug Therapy
3 Development and Manufacturing Plants Analysis of Diabetes Drug Therapy
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Diabetes Drug Therapy Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Diabetes Drug Therapy
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Diabetes Drug Therapy Production and Capacity Analysis
- 4.2 Diabetes Drug Therapy Revenue Analysis
- 4.3 Diabetes Drug Therapy Price Analysis
- 4.4 Market Concentration Degree
5 Diabetes Drug Therapy Regional Market Analysis
- 5.1 Diabetes Drug Therapy Production by Regions
- 5.1.1 Global Diabetes Drug Therapy Production by Regions
- 5.1.2 Global Diabetes Drug Therapy Revenue by Regions
- 5.2 Diabetes Drug Therapy Consumption by Regions
- 5.3 North America Diabetes Drug Therapy Market Analysis
- 5.3.1 North America Diabetes Drug Therapy Production
- 5.3.2 North America Diabetes Drug Therapy Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Diabetes Drug Therapy Import and Export
- 5.4 Europe Diabetes Drug Therapy Market Analysis
- 5.4.1 Europe Diabetes Drug Therapy Production
- 5.4.2 Europe Diabetes Drug Therapy Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Diabetes Drug Therapy Import and Export
- 5.5 China Diabetes Drug Therapy Market Analysis
- 5.5.1 China Diabetes Drug Therapy Production
- 5.5.2 China Diabetes Drug Therapy Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Diabetes Drug Therapy Import and Export
- 5.6 Japan Diabetes Drug Therapy Market Analysis
- 5.6.1 Japan Diabetes Drug Therapy Production
- 5.6.2 Japan Diabetes Drug Therapy Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Diabetes Drug Therapy Import and Export
- 5.7 Southeast Asia Diabetes Drug Therapy Market Analysis
- 5.7.1 Southeast Asia Diabetes Drug Therapy Production
- 5.7.2 Southeast Asia Diabetes Drug Therapy Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Diabetes Drug Therapy Import and Export
- 5.8 India Diabetes Drug Therapy Market Analysis
- 5.8.1 India Diabetes Drug Therapy Production
- 5.8.2 India Diabetes Drug Therapy Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Diabetes Drug Therapy Import and Export
6 Diabetes Drug Therapy Segment Market Analysis (by Type)
- 6.1 Global Diabetes Drug Therapy Production by Type
- 6.2 Global Diabetes Drug Therapy Revenue by Type
- 6.3 Diabetes Drug Therapy Price by Type
7 Diabetes Drug Therapy Segment Market Analysis (by Application)
- 7.1 Global Diabetes Drug Therapy Consumption by Application
- 7.2 Global Diabetes Drug Therapy Consumption Market Share by Application (2014-2019)
8 Diabetes Drug Therapy Major Manufacturers Analysis
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Diabetes Drug Therapy Production Sites and Area Served
- 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.1.3 Abbott Laboratories Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Mannkind Corporation
- 8.2.1 Mannkind Corporation Diabetes Drug Therapy Production Sites and Area Served
- 8.2.2 Mannkind Corporation Product Introduction, Application and Specification
- 8.2.3 Mannkind Corporation Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bristol Myers Squibb
- 8.3.1 Bristol Myers Squibb Diabetes Drug Therapy Production Sites and Area Served
- 8.3.2 Bristol Myers Squibb Product Introduction, Application and Specification
- 8.3.3 Bristol Myers Squibb Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Medtronic
- 8.4.1 Medtronic Diabetes Drug Therapy Production Sites and Area Served
- 8.4.2 Medtronic Product Introduction, Application and Specification
- 8.4.3 Medtronic Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 AstraZeneca
- 8.5.1 AstraZeneca Diabetes Drug Therapy Production Sites and Area Served
- 8.5.2 AstraZeneca Product Introduction, Application and Specification
- 8.5.3 AstraZeneca Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Eli Lilly and Company
- 8.6.1 Eli Lilly and Company Diabetes Drug Therapy Production Sites and Area Served
- 8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
- 8.6.3 Eli Lilly and Company Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 GlaxoSmithKline
- 8.7.1 GlaxoSmithKline Diabetes Drug Therapy Production Sites and Area Served
- 8.7.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.7.3 GlaxoSmithKline Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sanofi
- 8.8.1 Sanofi Diabetes Drug Therapy Production Sites and Area Served
- 8.8.2 Sanofi Product Introduction, Application and Specification
- 8.8.3 Sanofi Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Novo Nordisk
- 8.9.1 Novo Nordisk Diabetes Drug Therapy Production Sites and Area Served
- 8.9.2 Novo Nordisk Product Introduction, Application and Specification
- 8.9.3 Novo Nordisk Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Novartis International AG
- 8.10.1 Novartis International AG Diabetes Drug Therapy Production Sites and Area Served
- 8.10.2 Novartis International AG Product Introduction, Application and Specification
- 8.10.3 Novartis International AG Diabetes Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Diabetes Drug Therapy Market
- 9.1 Global Diabetes Drug Therapy Market Trend Analysis
- 9.1.1 Global Diabetes Drug Therapy Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Diabetes Drug Therapy Regional Market Trend
- 9.2.1 North America Diabetes Drug Therapy Forecast 2019-2025
- 9.2.2 Europe Diabetes Drug Therapy Forecast 2019-2025
- 9.2.3 China Diabetes Drug Therapy Forecast 2019-2025
- 9.2.4 Japan Diabetes Drug Therapy Forecast 2019-2025
- 9.2.5 Southeast Asia Diabetes Drug Therapy Forecast 2019-2025
- 9.2.6 India Diabetes Drug Therapy Forecast 2019-2025
- 9.3 Diabetes Drug Therapy Market Trend (Product Type)
- 9.4 Diabetes Drug Therapy Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Diabetes Drug Therapy Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Diabetes Drug Therapy. Industry analysis & Market Report on Diabetes Drug Therapy is a syndicated market report, published as Global Diabetes Drug Therapy Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Diabetes Drug Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
